Page 30 - Accessed May News Today : Breaking News, Live Updates & Top Stories | Vimarsana

For many people with diabetes, continuous glucose monitoring has become an indispensable tool to accurately monitor real-time blood glucose levels and track glucose trends over time.Since it was first approved by the FDA for professional use in 1999, CGM has become standard of care for people with type 1 diabetes, with data demonstrating benefits for improved glucose management, health outcomes

Udenyca (pegfilgrastim-cbqv), a biosimilar to Neulasta, is now available in a single-dose prefilled autoinjector presentation.

A proposed bill to make ordering contact lenses online safer by banning sellers from verifying prescriptions through robocalls has earned the praise of the Health Care Alliance for Patient Safety.

Adalimumab-adbm (Cyltezo Pen; Boehringer Ingelheim) is approved by the FDA as an interchangeable biosimilar to Humira.

Young investigators, fellows, and medical students recently gathered at the Temple University Lewis Katz School of Medicine in Philadelphia, Pennsylvania, to network and share exciting research aimed at addressing disparities in the dissemination of cancer care at the 5th Annual Regional Synergistic Partnership for Enhancing Equity in Cancer Health Conference and Retreat.